Vertex poaches B-MS exec as SVP international commercial ops

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that Ludovic Fenaux has been appointed senior vice president, international commercial operations with responsibility for commercial activities outside of the USA and Canada, which includes overseeing offices and operations across Europe, Australia and Latin America.

Mr Fenaux started his role with Vertex on August 20 and reports to Stuart Arbuckle, executive VP and chief commercial officer. Mr Fenaux is based at the International headquarters in London and succeeds Simon Bedson, who is retiring after seven years as Vertex’ SVP and general manager, international commercial operations and nearly 30 years in the pharmaceutical industry.

Since joining in 2011, Mr. Bedson has successfully led Vertex’s global expansion outside of North America, including the establishment of the company’s international headquarters and commercial offices and operations across Europe, Australia and Latin America.